Epidemiologic studies have emphasized the close relationship between high BP and cardiovascular disease (CVD). Recently published prospective studies have focus on systolic and pulse pressure (PP). Systolic BP seems to be a more important factor than diastolic BP on cardiovascular and all-cause mortality in older patients. PP reflects stiffness of the large arteries and increases with age. Increasingly, PP is recognized as an independent predictor of myocardial infarction, congestive heart failure, and cardiovascular death, even in hypertensive patients who undergo successful antihypertensive drug therapy, especially in older individuals. Chronic kidney disease (CKD) is a major public health problem. The progression of kidney disease and its associated cardiovascular complications are the major causes of morbidity and mortality. This holds true for all stages of kidney disease, including ESRD that requires renal replacement therapy. C hronic kidney disease (CKD) is a worldwide public health problem. There is a rising incidence and prevalence of ESRD, with poor outcome and high cost. ESRD that requires treatment with dialysis or transplantation is the most visible outcome of CKD. However, cardiovascular disease (CVD) also frequently is associated with CKD, which is important because individuals with CKD are more likely to die of CVD than to develop ESRD (1). CVD in CKD is treatable and potentially preventable, and CKD seems to be a risk factor for CVD (2). In 1998, the National Kidney Foundation Task Force issued a report that emphasized the high risk for CVD in CKD (3). This report showed that there was a high prevalence of CVD in CKD and that mortality as a result of CVD was 10 to 30 times higher in dialysis patients than in the general population. The task force recommended that patients with CKD be considered in the highest risk group. Go et al. (4) demonstrated that reduced estimated GFR Ͻ60 ml/min per 1.73 m 2 independently predicts the risk for death and cardiovascular events in individuals with or without known CVD.Most of the traditional CVD risk factors, such as older age, diabetes, systolic hypertension, left ventricular hypertrophy, and low HDL cholesterol, are highly prevalent in CKD. Several nontraditional factors, such hyperhomocysteinemia, oxidant stress, dyslipidemia, and elevated inflammatory markers, are associated with atherosclerosis. Oxidant stress and inflammation may be the primary mediators or the "missing link" that could explain the tremendous burden of CVD in CKD (2). The purpose of this review is to show the importance of pulse pressure (PP) as clinical marker of cardiovascular risk in patients with CKD.
PP as Cardiovascular Risk FactorThe principal components of BP consist of both a steady component (mean arterial pressure [MAP]) and a pulsatile component (PP). Major determinants of MAP are ventricular ejection and peripheral vascular resistance. PP, the difference between systolic BP (SBP) and diastolic BP (DBP), also is made up of two major components: One that is caused by ventri...